aluates Reports

$ 0.0

Automative

Global Antisense Therapy Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-16M13675

Global Antisense Therapy Market Research Report 2023

BUY CHAPTERS

Global Antisense Therapy Market Research Report 2025

Code: QYRE-Auto-16M13675

Report

September 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alnylam Pharmaceuticals

Ionis Pharmaceuticals Inc

Isarna Therapeutics

Arrowhead

Dicerna Pharmaceuticals

Quark Pharmaceuticals

Benitec Biopharma

Sylentis

Gradalis Inc

Sarepta Therapeutics

Biogen

Arbutus Biopharma (Tekmira)

Antisense Therapy Market

The global market for Antisense Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Antisense Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antisense Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Antisense Therapy in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Antisense Therapy include Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Inc., Arbutus Biopharma (Tekmira), Isarna Therapeutics, Arrowhead, Dicerna Pharmaceuticals, Quark Pharmaceuticals, Benitec Biopharma, Sylentis, Gradalis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Antisense Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Therapy.

The Antisense Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antisense Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antisense Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antisense Therapy Market Report

Report Metric	Details
Report Name	Antisense Therapy Market
Segment by Type	RNA Antisense Therapy DNA Antisense Therapy
Segment by Application	Cancer Cardiovascular HBV Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Inc., Arbutus Biopharma (Tekmira), Isarna Therapeutics, Arrowhead, Dicerna Pharmaceuticals, Quark Pharmaceuticals, Benitec Biopharma, Sylentis, Gradalis, Sarepta Therapeutics, Biogen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antisense Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antisense Therapy Market report?

Ans: The main players in the Antisense Therapy Market are Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Inc., Arbutus Biopharma (Tekmira), Isarna Therapeutics, Arrowhead, Dicerna Pharmaceuticals, Quark Pharmaceuticals, Benitec Biopharma, Sylentis, Gradalis, Sarepta Therapeutics, Biogen

What are the Application segmentation covered in the Antisense Therapy Market report?

Ans: The Applications covered in the Antisense Therapy Market report are Cancer, Cardiovascular, HBV, Other

What are the Type segmentation covered in the Antisense Therapy Market report?

Ans: The Types covered in the Antisense Therapy Market report are RNA Antisense Therapy, DNA Antisense Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antisense Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 RNA Antisense Therapy

1.2.3 DNA Antisense Therapy

1.3 Market by Application

1.3.1 Global Antisense Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Cardiovascular

1.3.4 HBV

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antisense Therapy Market Perspective (2020-2031)

2.2 Global Antisense Therapy Growth Trends by Region

2.2.1 Global Antisense Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Antisense Therapy Historic Market Size by Region (2020-2025)

2.2.3 Antisense Therapy Forecasted Market Size by Region (2026-2031)

2.3 Antisense Therapy Market Dynamics

2.3.1 Antisense Therapy Industry Trends

2.3.2 Antisense Therapy Market Drivers

2.3.3 Antisense Therapy Market Challenges

2.3.4 Antisense Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antisense Therapy Players by Revenue

3.1.1 Global Top Antisense Therapy Players by Revenue (2020-2025)

3.1.2 Global Antisense Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Antisense Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Antisense Therapy Revenue

3.4 Global Antisense Therapy Market Concentration Ratio

3.4.1 Global Antisense Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antisense Therapy Revenue in 2024

3.5 Global Key Players of Antisense Therapy Head office and Area Served

3.6 Global Key Players of Antisense Therapy, Product and Application

3.7 Global Key Players of Antisense Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antisense Therapy Breakdown Data by Type

4.1 Global Antisense Therapy Historic Market Size by Type (2020-2025)

4.2 Global Antisense Therapy Forecasted Market Size by Type (2026-2031)

5 Antisense Therapy Breakdown Data by Application

5.1 Global Antisense Therapy Historic Market Size by Application (2020-2025)

5.2 Global Antisense Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Antisense Therapy Market Size (2020-2031)

6.2 North America Antisense Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Antisense Therapy Market Size by Country (2020-2025)

6.4 North America Antisense Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antisense Therapy Market Size (2020-2031)

7.2 Europe Antisense Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Antisense Therapy Market Size by Country (2020-2025)

7.4 Europe Antisense Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antisense Therapy Market Size (2020-2031)

8.2 Asia-Pacific Antisense Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Antisense Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Antisense Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antisense Therapy Market Size (2020-2031)

9.2 Latin America Antisense Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Antisense Therapy Market Size by Country (2020-2025)

9.4 Latin America Antisense Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antisense Therapy Market Size (2020-2031)

10.2 Middle East & Africa Antisense Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Antisense Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Antisense Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alnylam Pharmaceuticals

11.1.1 Alnylam Pharmaceuticals Company Details

11.1.2 Alnylam Pharmaceuticals Business Overview

11.1.3 Alnylam Pharmaceuticals Antisense Therapy Introduction

11.1.4 Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025)

11.1.5 Alnylam Pharmaceuticals Recent Development

11.2 Ionis Pharmaceuticals, Inc.

11.2.1 Ionis Pharmaceuticals, Inc. Company Details

11.2.2 Ionis Pharmaceuticals, Inc. Business Overview

11.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Introduction

11.2.4 Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2020-2025)

11.2.5 Ionis Pharmaceuticals, Inc. Recent Development

11.3 Arbutus Biopharma (Tekmira)

11.3.1 Arbutus Biopharma (Tekmira) Company Details

11.3.2 Arbutus Biopharma (Tekmira) Business Overview

11.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Introduction

11.3.4 Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2020-2025)

11.3.5 Arbutus Biopharma (Tekmira) Recent Development

11.4 Isarna Therapeutics

11.4.1 Isarna Therapeutics Company Details

11.4.2 Isarna Therapeutics Business Overview

11.4.3 Isarna Therapeutics Antisense Therapy Introduction

11.4.4 Isarna Therapeutics Revenue in Antisense Therapy Business (2020-2025)

11.4.5 Isarna Therapeutics Recent Development

11.5 Arrowhead

11.5.1 Arrowhead Company Details

11.5.2 Arrowhead Business Overview

11.5.3 Arrowhead Antisense Therapy Introduction

11.5.4 Arrowhead Revenue in Antisense Therapy Business (2020-2025)

11.5.5 Arrowhead Recent Development

11.6 Dicerna Pharmaceuticals

11.6.1 Dicerna Pharmaceuticals Company Details

11.6.2 Dicerna Pharmaceuticals Business Overview

11.6.3 Dicerna Pharmaceuticals Antisense Therapy Introduction

11.6.4 Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025)

11.6.5 Dicerna Pharmaceuticals Recent Development

11.7 Quark Pharmaceuticals

11.7.1 Quark Pharmaceuticals Company Details

11.7.2 Quark Pharmaceuticals Business Overview

11.7.3 Quark Pharmaceuticals Antisense Therapy Introduction

11.7.4 Quark Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025)

11.7.5 Quark Pharmaceuticals Recent Development

11.8 Benitec Biopharma

11.8.1 Benitec Biopharma Company Details

11.8.2 Benitec Biopharma Business Overview

11.8.3 Benitec Biopharma Antisense Therapy Introduction

11.8.4 Benitec Biopharma Revenue in Antisense Therapy Business (2020-2025)

11.8.5 Benitec Biopharma Recent Development

11.9 Sylentis

11.9.1 Sylentis Company Details

11.9.2 Sylentis Business Overview

11.9.3 Sylentis Antisense Therapy Introduction

11.9.4 Sylentis Revenue in Antisense Therapy Business (2020-2025)

11.9.5 Sylentis Recent Development

11.10 Gradalis

11.10.1 Gradalis Company Details

11.10.2 Gradalis Business Overview

11.10.3 Gradalis Antisense Therapy Introduction

11.10.4 Gradalis Revenue in Antisense Therapy Business (2020-2025)

11.10.5 Gradalis Recent Development

11.11 Sarepta Therapeutics

11.11.1 Sarepta Therapeutics Company Details

11.11.2 Sarepta Therapeutics Business Overview

11.11.3 Sarepta Therapeutics Antisense Therapy Introduction

11.11.4 Sarepta Therapeutics Revenue in Antisense Therapy Business (2020-2025)

11.11.5 Sarepta Therapeutics Recent Development

11.12 Biogen

11.12.1 Biogen Company Details

11.12.2 Biogen Business Overview

11.12.3 Biogen Antisense Therapy Introduction

11.12.4 Biogen Revenue in Antisense Therapy Business (2020-2025)

11.12.5 Biogen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alnylam Pharmaceuticals

Ionis Pharmaceuticals Inc

Isarna Therapeutics

Arrowhead

Dicerna Pharmaceuticals

Quark Pharmaceuticals

Benitec Biopharma

Sylentis

Gradalis Inc

Sarepta Therapeutics

Biogen

Arbutus Biopharma (Tekmira)

List of Tables

Table 1. Global Antisense Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of RNA Antisense Therapy

Table 3. Key Players of DNA Antisense Therapy

Table 4. Global Antisense Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Antisense Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Antisense Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Antisense Therapy Market Share by Region (2020-2025)

Table 8. Global Antisense Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Antisense Therapy Market Share by Region (2026-2031)

Table 10. Antisense Therapy Market Trends

Table 11. Antisense Therapy Market Drivers

Table 12. Antisense Therapy Market Challenges

Table 13. Antisense Therapy Market Restraints

Table 14. Global Antisense Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Antisense Therapy Market Share by Players (2020-2025)

Table 16. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2024)

Table 17. Ranking of Global Top Antisense Therapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Antisense Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Antisense Therapy, Headquarters and Area Served

Table 20. Global Key Players of Antisense Therapy, Product and Application

Table 21. Global Key Players of Antisense Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Antisense Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Antisense Therapy Revenue Market Share by Type (2020-2025)

Table 25. Global Antisense Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Antisense Therapy Revenue Market Share by Type (2026-2031)

Table 27. Global Antisense Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Antisense Therapy Revenue Market Share by Application (2020-2025)

Table 29. Global Antisense Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Antisense Therapy Revenue Market Share by Application (2026-2031)

Table 31. North America Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Antisense Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Antisense Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Antisense Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Antisense Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Antisense Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Antisense Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Antisense Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Antisense Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Antisense Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Antisense Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Antisense Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Alnylam Pharmaceuticals Company Details

Table 47. Alnylam Pharmaceuticals Business Overview

Table 48. Alnylam Pharmaceuticals Antisense Therapy Product

Table 49. Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 50. Alnylam Pharmaceuticals Recent Development

Table 51. Ionis Pharmaceuticals, Inc. Company Details

Table 52. Ionis Pharmaceuticals, Inc. Business Overview

Table 53. Ionis Pharmaceuticals, Inc. Antisense Therapy Product

Table 54. Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 55. Ionis Pharmaceuticals, Inc. Recent Development

Table 56. Arbutus Biopharma (Tekmira) Company Details

Table 57. Arbutus Biopharma (Tekmira) Business Overview

Table 58. Arbutus Biopharma (Tekmira) Antisense Therapy Product

Table 59. Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 60. Arbutus Biopharma (Tekmira) Recent Development

Table 61. Isarna Therapeutics Company Details

Table 62. Isarna Therapeutics Business Overview

Table 63. Isarna Therapeutics Antisense Therapy Product

Table 64. Isarna Therapeutics Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 65. Isarna Therapeutics Recent Development

Table 66. Arrowhead Company Details

Table 67. Arrowhead Business Overview

Table 68. Arrowhead Antisense Therapy Product

Table 69. Arrowhead Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 70. Arrowhead Recent Development

Table 71. Dicerna Pharmaceuticals Company Details

Table 72. Dicerna Pharmaceuticals Business Overview

Table 73. Dicerna Pharmaceuticals Antisense Therapy Product

Table 74. Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 75. Dicerna Pharmaceuticals Recent Development

Table 76. Quark Pharmaceuticals Company Details

Table 77. Quark Pharmaceuticals Business Overview

Table 78. Quark Pharmaceuticals Antisense Therapy Product

Table 79. Quark Pharmaceuticals Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 80. Quark Pharmaceuticals Recent Development

Table 81. Benitec Biopharma Company Details

Table 82. Benitec Biopharma Business Overview

Table 83. Benitec Biopharma Antisense Therapy Product

Table 84. Benitec Biopharma Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 85. Benitec Biopharma Recent Development

Table 86. Sylentis Company Details

Table 87. Sylentis Business Overview

Table 88. Sylentis Antisense Therapy Product

Table 89. Sylentis Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 90. Sylentis Recent Development

Table 91. Gradalis Company Details

Table 92. Gradalis Business Overview

Table 93. Gradalis Antisense Therapy Product

Table 94. Gradalis Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 95. Gradalis Recent Development

Table 96. Sarepta Therapeutics Company Details

Table 97. Sarepta Therapeutics Business Overview

Table 98. Sarepta Therapeutics Antisense Therapy Product

Table 99. Sarepta Therapeutics Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 100. Sarepta Therapeutics Recent Development

Table 101. Biogen Company Details

Table 102. Biogen Business Overview

Table 103. Biogen Antisense Therapy Product

Table 104. Biogen Revenue in Antisense Therapy Business (2020-2025) & (US$ Million)

Table 105. Biogen Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Antisense Therapy Picture

Figure 2. Global Antisense Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antisense Therapy Market Share by Type: 2024 VS 2031

Figure 4. RNA Antisense Therapy Features

Figure 5. DNA Antisense Therapy Features

Figure 6. Global Antisense Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Antisense Therapy Market Share by Application: 2024 VS 2031

Figure 8. Cancer Case Studies

Figure 9. Cardiovascular Case Studies

Figure 10. HBV Case Studies

Figure 11. Other Case Studies

Figure 12. Antisense Therapy Report Years Considered

Figure 13. Global Antisense Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Antisense Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Antisense Therapy Market Share by Region: 2024 VS 2031

Figure 16. Global Antisense Therapy Market Share by Players in 2024

Figure 17. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Antisense Therapy Revenue in 2024

Figure 19. North America Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Antisense Therapy Market Share by Country (2020-2031)

Figure 21. United States Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Antisense Therapy Market Share by Country (2020-2031)

Figure 25. Germany Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Antisense Therapy Market Share by Region (2020-2031)

Figure 33. China Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Antisense Therapy Market Share by Country (2020-2031)

Figure 41. Mexico Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Antisense Therapy Market Share by Country (2020-2031)

Figure 45. Turkey Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Antisense Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 49. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 50. Arbutus Biopharma (Tekmira) Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 51. Isarna Therapeutics Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 52. Arrowhead Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 53. Dicerna Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 54. Quark Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 55. Benitec Biopharma Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 56. Sylentis Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 57. Gradalis Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 58. Sarepta Therapeutics Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 59. Biogen Revenue Growth Rate in Antisense Therapy Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Antisense Oligonucleotide ASO Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antisense Oligonucleotides ASO Drug Market Research Report 2024

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nucleic Acid Based Gene Therapeutics Market Research Report 2024

Global mRNA Treatment Market Research Report 2024

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024

Global Anti Neoplastic Therapy Market Research Report 2024

Antiviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global In Vitro Gene Therapy Market Research Report 2025

Global RNA Seq Market Research Report 2024

Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global RNase Inhibitor Market Research Report 2025

Global Epigenetic Therapeutics Market Research Report 2024

Global RNA Interference Technology Market Research Report 2025

Global siRNA Drug Market Research Report 2024

Global Gene Editing Therapy Market Research Report 2024

Global Cell and Gene Therapy Solutions Market Research Report 2025

Global Non viral Vectors Gene Therapy Market Research Report 2025

Global Oligonucleotide Array Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions